Abbott Laboratories (ABT)
115.03
-0.71
(-0.61%)
USD |
NYSE |
Nov 14, 16:00
115.06
+0.02
(+0.02%)
Pre-Market: 20:00
Abbott Laboratories Cash and Short Term Investments (Quarterly): 7.788B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 7.788B |
June 30, 2024 | 7.219B |
March 31, 2024 | 6.651B |
December 31, 2023 | 7.279B |
September 30, 2023 | 7.047B |
June 30, 2023 | 8.155B |
March 31, 2023 | 9.532B |
December 31, 2022 | 10.17B |
September 30, 2022 | 9.907B |
June 30, 2022 | 9.29B |
March 31, 2022 | 8.158B |
December 31, 2021 | 10.25B |
September 30, 2021 | 9.692B |
June 30, 2021 | 8.944B |
March 31, 2021 | 8.372B |
December 31, 2020 | 7.148B |
September 30, 2020 | 4.731B |
June 30, 2020 | 5.037B |
March 31, 2020 | 3.668B |
December 31, 2019 | 4.14B |
September 30, 2019 | 4.335B |
June 30, 2019 | 3.376B |
March 31, 2019 | 3.261B |
December 31, 2018 | 4.086B |
September 30, 2018 | 7.55B |
Date | Value |
---|---|
June 30, 2018 | 3.264B |
March 31, 2018 | 4.042B |
December 31, 2017 | 9.61B |
September 30, 2017 | 11.20B |
June 30, 2017 | 9.835B |
March 31, 2017 | 8.86B |
December 31, 2016 | 18.78B |
September 30, 2016 | 4.507B |
June 30, 2016 | 4.438B |
March 31, 2016 | 3.957B |
December 31, 2015 | 6.125B |
September 30, 2015 | 6.139B |
June 30, 2015 | 11.18B |
March 31, 2015 | 9.849B |
December 31, 2014 | 4.46B |
September 30, 2014 | 4.877B |
June 30, 2014 | 7.062B |
March 31, 2014 | 7.047B |
December 31, 2013 | 8.098B |
September 30, 2013 | 8.605B |
June 30, 2013 | 9.394B |
March 31, 2013 | 8.517B |
December 31, 2012 | 15.17B |
September 30, 2012 | 11.50B |
June 30, 2012 | 11.00B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.668B
Minimum
Mar 2020
10.25B
Maximum
Dec 2021
7.659B
Average
7.972B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Boston Scientific Corp | 2.502B |
Becton Dickinson & Co | 2.162B |
ResMed Inc | 426.36M |
Globus Medical Inc | 694.71M |
Insulet Corp | 902.60M |